相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPAR-independent pathway
Masanobu Tsubaki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Inhibition of NF-κB prevents the acidic bile-induced oncogenic mRNA phenotype, in human hypopharyngeal cells
Dimitra P. Vageli et al.
Oncotarget (2017)
Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
Hua Qu et al.
SCIENTIFIC REPORTS (2017)
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
Elena Filipova et al.
DIABETES THERAPY (2017)
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
Elena Filipova et al.
DIABETES THERAPY (2017)
Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms
Lili Wang et al.
CANCER LETTERS (2017)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer
Zoran Culig
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes
James D. Lewis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Observational follow-up of the PROactive study: a 6-year update
E. Erdmann et al.
DIABETES OBESITY & METABOLISM (2014)
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors
David Della-Morte et al.
PHARMACOGENOMICS (2014)
Can genome engineering be used to target cancer-associated enhancers?
Matthew R. Grimmer et al.
EPIGENOMICS (2014)
Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
M. Ferwana et al.
DIABETIC MEDICINE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Outcomes and lessons from the PROactive study
Andre J. Scheen
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Rat Urinary Bladder Carcinogenesis by Dual-Acting PPAR alpha plus gamma Agonists
Martin B. Oleksiewicz et al.
PPAR RESEARCH (2008)
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
Maria E. Ramos-Nino et al.
BMC MEDICINE (2007)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
分享论文
